People · Operator
Named in public records as an officer, director or promoter · active 2012–2021 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Harrow Health, Inc. | — | Pharmaceuticals | Series A | $29.2M | $226.5M | 2012 |
| Emerald Health Pharmaceuticals Inc. | — | Pharmaceuticals | Seed | $3.3M | $6.9M | 2021 |
Joachim Schupp at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Joachim Schupp on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Teresa F. Sparks | 1 | 30 |
| Richard Lindstrom | 1 | 13 |
| Paul Finnegan | 1 | 11 |
| Richard L Lindstrom | 1 | 8 |
| Mark L. Baum | 1 | 5 |
| Punit Dhillon | 1 | 4 |
| Mark Baum | 1 | 4 |
| Andrew Boll | 1 | 3 |
| James L. Heppell | 1 | 2 |
| Robert Kammer | 1 | 2 |
| James DeMesa | 1 | 2 |
| Punit S. Dhillon | 1 | 2 |
| Gaetano Morello | 1 | 2 |
| Robert J. Kammer | 1 | 1 |
| Balbir Brar | 1 | 1 |
| Alain S. Rolland | 1 | 1 |
| James L. Hepell | 1 | 1 |
| Jeffrey Abrams | 1 | 1 |
| Joachim S. Schupp | 1 | 1 |
| R Larry Van Horn | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.